Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2012.09.008
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2012
Authors
Publisher
Elsevier BV